Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …

Background Cancer patients with coronavirus disease 2019 (COVID-19) have been
reported to have double the case fatality rate of the general population. Methods A …

Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …

Background Individuals with cancer, particularly those who are receiving systemic
anticancer treatments, have been postulated to be at increased risk of mortality from COVID …

Objective To determine the incidence of hospital admissions and associated mortality rates
for non-covid medical conditions during the covid-19 pandemic. Design Nationwide …

We established an international consortium to review and discuss relevant clinical evidence
in order to develop expert consensus statements related to cancer management during the …

Background Children with cancer are frequently immunocompromised. While children are
generally thought to be at less risk of severe SARS-CoV-2 infection than adults …

Purpose Pediatric oncology patients undergoing active chemotherapy are suspected to be
at a high risk for severe disease secondary to severe acute respiratory syndrome …

Much of routine cancer care has been disrupted due to the perceived susceptibility to SARS-
CoV-2 infection in cancer patients. Here, we systematically review the current evidence base …

The coronavirus disease 2019 (COVID-19) is currently representing a global health threat
especially for fragile individuals, such as cancer patients. It was demonstrated that cancer …